Navidea Biopharmaceuticals, Inc. (NYSE American: NAVB) (“Navidea” or the “Company”), a company focused on the development of precision immunodiagnostic agents and immunotherapeutics, today announced it will host a conference call and webcast on Thursday, August 8, 2019 at 5:00 p.m. (EDT) to discuss its financial results for the second quarter of 2019.
August 1, 2019
· 4 min read